Should You Order a Repeat Type-and-Screen After Transfusing pRBCs?
No, you do not need to routinely order a repeat type-and-screen after a patient receives a unit of packed red blood cells, unless there are specific clinical indications such as suspected antibody formation, transfusion reactions, or the need for additional transfusions in high-risk patients.
Clinical Context and Rationale
The decision to repeat type-and-screen testing is not addressed in major perioperative or critical care transfusion guidelines 1, 2. These guidelines focus on restrictive transfusion strategies, single-unit transfusion protocols, and patient blood management, but do not mandate routine repeat antibody screening after each transfusion episode.
When to Consider Repeat Type-and-Screen
High-Risk Scenarios for Alloimmunization
The risk of developing new red cell antibodies (alloimmunization) after transfusion is relatively low but increases with:
- Multiple transfusions: Patients receiving more than 3 units have an 8.4-fold increased risk of alloimmunization 3
- Female patients: Higher risk compared to males 3
- Massive transfusion protocol (MTP) patients: Even with uncrossmatched blood, alloimmunization occurs in only 3.6% of cases 4
Specific Indications for Repeat Testing
Order a repeat type-and-screen if:
- Patient requires additional transfusions beyond the initial unit (following single-unit transfusion strategy 2)
- Transfusion reaction occurs or is suspected
- Patient is in a massive transfusion protocol and will need ongoing blood products
- Patient has history of prior antibodies or difficult crossmatches
- More than 3 days have passed since the original type-and-screen and additional transfusions are needed
- Patient is female of childbearing age or has multiple prior transfusions (higher alloimmunization risk)
Standard Practice Approach
For Single-Unit Transfusion
Following current guidelines recommending single-unit transfusion with reassessment 2:
- Transfuse one unit of pRBCs
- Reassess clinical status (hemoglobin, vital signs, organ perfusion)
- If additional transfusion needed, the original type-and-screen remains valid for the timeframe specified by your institution (typically 72 hours to 3 days)
- Order repeat type-and-screen only if outside the valid timeframe or high-risk features present
For Ongoing Transfusion Needs
If the patient will require multiple units over days:
- The original type-and-screen typically remains valid for 72 hours
- After this period, institutional protocols usually require repeat testing
- This is standard blood bank practice, not necessarily evidence-based
Important Caveats
Newly developed antibodies post-transfusion are clinically significant and can cause hemolysis 4. However, antibody formation takes time (typically days to weeks), so immediate repeat testing after a single unit is not useful for detecting new antibodies.
The most common antibodies that develop are in the Rh system (38.8%), followed by MNS (25%) and Lewis (27.7%) blood group systems 3. These typically manifest in patients requiring chronic transfusion support, not after a single unit.
Communication with your blood bank is essential if there are concerns about blood type accuracy or prior antibody history 5. Trust the blood bank's testing—modern techniques are highly accurate.